Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abciximab
abdominal protrusion
abdominal reflex, absent
abortion, spontaneous
acetylcholine receptor
acetylcholine receptor antibody
acoustic neurinoma
acquired immunodeficiency syndrome
acute coronary syndrome
acute intermittant porphyria
acyclovir
adalimumab
Addison's disease
aducanumab
advances in neurology
adverse drug reaction
afebrile
alemtuzumab
algorithm
alopecia
Alzheimer's disease
Alzheimer's disease, early onset
Alzheimer's disease, treatment of
amblyopia, toxic
AMPA receptor antibodies
amyloid
amyloid beta protein
amyloid beta protein antibodies
amyloid deposition
amyloid plaques
amyloidosis
amyloid-related imaging abnormalities
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, work up
anasarca
anemia
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiography, cerebral
angiotensin-converting enzyme
ankle edema
ankylosing spondylitis
anti GQ1b IgG antibody
anti JC virus antibodies
anti MAG antibodies
anti Yo antibody
anti-amyloid therapy
anticardiolipin antibodies
anticoagulant, complications of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antineutrophil cytoplasmic autoantibodies
antiphospholipid antibodies
anxiety
aortic wall, thickened
aortitis
aphasia
apolipoprotein E
apoliprotein E, plasma level
arachnoiditis
area postrema
area postrema syndrome
areflexia
arteritides
arteritis, temporal
arteritis, temporal, recurrent
arthralgia
ascites
aspergillosis
aspirin
asymptomatic
ataxia
ataxia, cerebellar
ataxia, progressive
ataxia, sensory
atezolizumab
atypical
autism
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autoimmune encephalopathy
autonomic dysfunction
axonal degeneration
axonal regeneration
azathioprine
B 12 deficiency
B cell lymphocyte depletion
B cell lymphocytes
bacterial endocarditis, neurologic manifestations of
bacterial infection, CNS
basal ganglia, lesion of
basal ganglia, lesion, bilateral
basilar artery occlusion
basilar artery stenosis
behavioral disorder
behavioral disorder, acute
Behcet's syndrome
Bence Jones protein
bevacizumab
biologic markers
blacks
blindness
blood cultures
bone marrow biopsy
bone marrow transplantation
bone survey
bone survey, metastatic
border zone infarct
brachial plexus injury
brachial plexus neuropathy
bradykinesia
brain atrophy
brain biopsy
brain biopsy, false negative
brain biopsy, negative
brainstem
brainstem, lesion of
brentuximab
Broca's aphasia
bulbar palsy
bulbar palsy, progressive
burning feet
burning paresthesia
bursitis
cachexia
calcification, intracranial
calcitonin gene related peptide
calcitonin gene-related peptide receptor blocker
camptocormia
cancer associated myopathy
candida albicans
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of ovary
cardiac surgery
cardiac surgery, neurologic complications with
cardiac transplantation
cardiotoxicity
carotid artery, enlarged external diameter
carpal tunnel syndrome
Castleman's disease
CAT scan
CAT scan, abdomen
CAT scan, abnormal
CAT scan, angiography
CAT scan, base of skull
CAT scan, chest
CAT scan, contrast enhanced
CAT scan, contrast enhanced, subepend.
CAT scan, dense artery sign
CAT scan, dense artery sign, disappearing
CAT scan, emission, abnormal
catatonia
cauda equina
cauda equina, enhancement
cauda equina, lesion of
CD4 counts
central nervous system, infection of
central retinal vein occlusion
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar infarction
cerebellar lesion
cerebellitis
cerebellitis, autoimmune
cerebellum, disease of
cerebral arteries
cerebral cortex
cerebral edema
cerebral edema, vasogenic
cerebral hypersensitivity, delayed
cerebral infarction
cerebral infarction, hemorrhagic
cerebral ischemia
cerebral venous thrombosis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS tumors
cerebrospinal fluid, cytology
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, gammaglobulin of
cerebrospinal fluid, immunoglobulins of
cerebrospinal fluid, oligoclonal IgG in
cerebrospinal fluid, proteincytologic dissociation
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, awakening with
cerebrovascular accident, multiple
cerebrovascular accident, prevention of
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, young adult
cerebrovascular disease
chairbound
chemotherapy, CNS treatment and complications with
chest pain
chest x-ray, abnormal
children
cholangitis
cholecystitis
chorea
choreoathetosis
cladribine
Clinical Pathologic Conference(C.P.C.)
cluster headache
coagulopathy
cognition
coinfection
collapsin response mediator protein 5 IgG
coma
comorbidities
complement
complications
conduction block
confusion
confusional state, acute
congenital malformation
congestive heart failure
contraindications
controversies in neurology
cop 1
corneal dystrophy
corpus callosum, lesion of
cost
cost effectiveness
cranial nerve palsies
cranial nerve palsies, recurrent
cranial neuropathy
cranial neuropathy, multiple
C-reactive protein, elevated
creatine phosphokinase(CPK)elevated
critical care unit
cryoglobulinemia
cyclophosphamide
cyclosporine
cytokines
cytomegalovirus infection
daclizumab
delay in diagnosis
dementia
dementia, autoimmune
dementia, rapidly progressive
dementia, reversible
dementia, treatment of
demyelinating disease
denervation of muscle
denervation potentials
dentate nuclei
dentate nuclei, lesion of
dermatomyositis
developmental milestones, loss of
diabetes insipidus
diabetes mellitus
diagnostic criteria
diarrhea
differential diagnosis
difficulty climbing stairs
diplopia
disability rating scale, neurological
disability, neurological
disease modifying agents
disorientation
distal muscle atrophy
distal muscle weakness
diurnal variation
dizziness
donanemab
DPPX, antibodies, encephalitis
dropped head syndrome
drug abuse
drug holiday
drug induced neurologic disorders
drug withdrawal
duvalumab
dysarthria
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, facial
dysphagia
dyspnea
dystonia
echocardiogram
eculizumab
edema, leg
edema, pedal
edema, periorbital
efalizumab
efficacy
efgartigimod alfa
electrocardiogram, abnormal
electroencephalogram, abnormalities of
electromyogram
electron microscopy
electrophoretic pattern, serum
electrophoretic pattern, urine
embolism, vertebral-basilar artery
emotional lability
encephalitis
encephalitis, acanthamoeba
encephalitis, amebic
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy
encephalopathy, anoxic
encephalopathy, delayed
endocarditis
endocarditis, infectious
endocarditis, subacute bacterial
endocarditis, treatment of
eosinophilia
eosinophilic granulomatosis with polyangiitis
epidemiology of neurology
episodic disorders
epistaxis
epistaxis, recurrent
Epstein-Barr virus
Epstein-Barr virus, negative
eptinezumab
erectile dysfunction
erenumab
erythropoietin
erythropoietin treatment
etanercept
evidence-based research
extralimbic encephalitis
extraocular muscle enlargement
extraocular muscle lesion
eye movement, painful
eye, pain in
face, numbness of
facial nerve palsy
facial nerve palsy, bilateral
facial pain
facial weakness, bilateral
faciobrachial dystonic seizure
falling
false negative
false positive
fasciculation
fatigue
fetus
fever
fibrillations
fibrinogen
fibrinolytic agents
fibrinolytic agents, intra-arterial local infusion
fingolimod
Fisher's syndrome
fluorescein angiography
foot drop
foot drop, bilateral
fremanezumab
frexalimab
fumarate
fungal infection, CNS
F-wave response
gadolinium
gait disorder
galcanezumab
gallium scan
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gangliosides
gantenerumab
gender
giant cell arteritis
glioblastoma multiforme(astrocytoma Gr.III)
glioma
glutamic acid decarboxylase, antibody
GM1 ganglioside antibodies
granuloma, eosinophilic
granulomatosis with polyangiitis
granulomatous disease
granulomatous hypophysitis
Guillain Barre syndrome
Guillain Barre syndrome, differential diagnosis of
gynecomastia
hallucination
hallucination, olfactory
hallucination, visual
halo sign
headache
headache, children
headache, drug induced
headache, episodic
headache, preventive treatment
headache, prophylaxis
headache, recurrent
headache, severe
headache, treatment of
headache, unilateral
hearing loss
heart murmur
hemianopia
hemiparesis
hemiplegia, progressive
hemoglobinuria
hemolysis
hemophagocytic lymphohistiocytosis
hemorrhagic diathesis
hemosiderosis of CNS, superficial
hemosiderosis, subarachnoid
heparin
heparinoid, low molecular weight
hepatic failure
hepatomegaly
hepatosplenomegaly
heralding manifestation
herpes simplex encephalitis
herpes simplex encephalitis, atypical
herpes simplex virus infection, immunosuppressed patient
herpes virus infection
herpes zoster
hiccoughs
highly active antiretroviral therapy
hip flexor weakness
hippocampus
histochemistry of muscle
HLA
hoarseness
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hormone replacement
human immunodeficiency virus type 1
hydrocephalus
hypercalcemia
hyperekplexia
hypereosinophilic syndrome(HES)
hyperpigmentation of skin
hypersensitivity reaction
hypertension
hypertensive retinopathy
hypertrichosis
hypertrophic intracranial pachymeningitis
hyperviscosity
hyperviscosity syndrome
hypoglycorrhachia
hypogonadism
hyponatremia
hypophysitis, IgG4-related
hypopigmentation of skin
hypothalamus, lesion of
hypoxia
iatrogenic neurologic disorders
idiopathic thrombocytopenic purpura
IgG4, serum
IgG4-related disease
imbalance
immune checkpoint inhibitors
immune reconstitution inflammatory syndrome
immune-related adverse events
immunocompetent
immunoelectrophoresis, serum
immunofluorescence
immunologic disease
immunology and the nervous system
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
impotence
in situ hybridization
inappropriate antidiuretic(A.D.H.)hormone
inborn errors of metabolism, screening
incidental finding
inebilizumab
infection
infliximab
infusion-associated reaction
insomnia
intellectual deficit
interferon
interferon beta 1-a
interferon beta 1-b
interleukin 2
interleukin 6
internal carotid artery
intracerebral hemorrhage
intracerebral hemorrhage, lobar
intracerebral hemorrhage, small
intracranial hypertension, benign
intrauterine
ipilimumab
iritis
iron, serum, elevated
Janus kinase inhibitors
JC virus
JC virus cerebellar granule cell neuronopathy
JC virus encephalopathy
lacrimal gland enlargement
lactic dehydrogenase(LDH)
lactobacillus
laquinimod
lecanemab
leg atrophy
leg numbness
leg weakness, bilateral
leprosy
leucine rich glioma inactivated 1 antibodies
leukemia
leukemia, neurologic findings assoc.with
leukocytosis
leukoencephalopathy
leukoencephalopathy, toxic
leukopenia
levamisole
level of consciousness, decreased
life expectancy
lightheaded
limb-girdle weakness
limbic encephalitis
lipoprotein receptor-related protein 4
listeria monocytogenes
liver function enzymes
long bone lesion
low back pain
lumbar puncture
lupus anticoagulant
lymph node biopsy
lymphadenopathy
lymphadenopathy, cervical
lymphadenopathy, hilar
lymphoma
lymphoma involving CNS
lymphoma, primary of CNS
lymphomatoid granulomatosis
lymphopenia
macroglobulinemia
masseter muscle wasting
medial rectus palsy
mediastinum, lymph-node biopsy
mediastinum, mass of
medication withdrawal
medulla oblongata
medulla oblongata, lesion of
melanoma, malignant
melphalan
memory, defect of recent
memory, impairment of
meningeal biopsy
meningeal enhancement
meningismus
meningitis
meningitis, aseptic
meningitis, bacterial
meningitis, basilar
meningitis, carcinomatous
meningitis, chronic
meningitis, drug induced
meningitis, iatrogenic
meningitis, listeria monocytogenes
meningitis, lymphomatous
meningitis, neutrophilic
meningitis, noninfectious
meningitis, pneumococcal
meningitis, recurrent
meningitis, TB
meningoencephalitis
meningoencephalopathy
meningomyelitis
mental status, abnormal
mercaptopurine
mesial temporal lobe
methotrexate
microhemorrhage, intracerebral
microscopic polyangiitis
microsporidia
middle cerebellar peduncle
middle cerebellar peduncle, lesion
middle cerebral artery
middle cerebral artery, occlusion of
migraine
migraine, children
migraine, chronic
migraine, intractable
migraine, pathogenesis
migraine, prophylaxis
migraine, treatment of
Mikulicz's syndrome
mild cognitive impairment
mimics
misdiagnosis
monoclonal antibodies
monoclonal antibodies for tumor cells in CSF
monoclonal gammopathy
monoclonal gammopathy of uncertain significance
mononeuritis multiplex
mononeuritis multiplex, causes of
mononeuropathy
mononeuropathy multiplex
mood change
mortality
mosquito
motor neuron disease
movement disorder
MRI
MRI, abnormal
MRI, angiography
MRI, contrast enhanced
MRI, contrast enhanced, cloud-like
MRI, demyelinating disease
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, false negative
MRI, FLAIR
MRI, lesion burden
MRI, magnetization transfer sequence
MRI, mass effect on
MRI, negative
MRI, nodular enhancement
MRI, optic nerve
MRI, orbit
MRI, punctate pattern
MRI, ring sign
MRI, ring sign, open
MRI, serial
MRI, skull bone changes
MRI, spinal cord
MRI, spinal cord, increased intramedullary cord signal
MRI, vessel wall
MRS
multifocal fibrosclerosis
multinucleated giant cell
multiple myeloma
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, diagnosis of
multiple sclerosis, differential diagnosis of
multiple sclerosis, disability status scale
multiple sclerosis, disease activity
multiple sclerosis, etiology of
multiple sclerosis, misdiagnosis
multiple sclerosis, pathogenesis
multiple sclerosis, plaque
multiple sclerosis, prophylaxsis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
muromonab-CD3
muscle atrophy, progressive
muscle biopsy
muscle biopsy, extraocular
muscle pain
muscle stiffness
muscle wasting, diffuse
muscle weakness
muscle weakness, proximal
muscle weakness, sudden onset of
MuSK antibodies
mutism
myasthenia gravis
myasthenia gravis, classification
myasthenia gravis, diagnosis
myasthenia gravis, drug induced
myasthenia gravis, drug resistant
myasthenia gravis, infantile and juvenile
myasthenia gravis, ocular
myasthenia gravis, receptor site in
myasthenia gravis, seronegative
myasthenia gravis, thymectomy in
myasthenia gravis, treatment of
myasthenia gravis, variants
myasthenic crisis
myasthenic syndrome
mycophenolate
myelitis
myelitis, longitudinal
myelitis, transverse
myelitis, transverse, recurrent
myeloma, osteosclerotic
myelopathy
myocarditis
myoclonus
myopathy
myopathy, amyloid
myopathy, inflammatory
myopathy, necrotizing
myopathy, necrotizing, immune-mediated
myopathy, proximal
myopathy, steroid responsive
myositis
myositis, ocular
nasal speech
natalizumab
natalizumab antibodies
natalizumab, discontinuation
nausea and vomiting
near syncope
neck stiffness
neck weakness
necrotizing vasculitis
negative
nemaline rod myopathy
nemaline rod myopathy, adult onset
neoplasm, metastatic
neoplasm, metastatic to CNS
neoplasm, metastatic to CNS-treatment of
neoplasm, primary intracerebral
neoplasm, primary of CNS
neoplasm, primary of CNS-differential diagnosis
neoplasm, primary of CNS-recurrent
neoplasm, primary of CNS-survival
neoplasm, primary of CNS-treatment of
neoplastic angioendotheliosis
nerve biopsy
nerve conduction studies
nerve conduction studies, motor
neurexin-3 alpha antibodies
neuroendocrinology
neurofibromatosis 2
neurofilament light chain protein
neurologic complications
neurologic complications of, systemic cancer
neurologic complications of, systemic disease
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic signs
neurologic symptoms
neurolymphomatosis
neuromuscular disease, electrodiagnosis of
neuromuscular junction
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuronal cell surface antigen
neuronopathy
neuroophthalmology
neuropathology
neuropathy
neuropathy, amyloid
neuropathy, asymptomatic
neuropathy, ataxic
neuropathy, chronic
neuropathy, cryoglobulinemic
neuropathy, demyelinating
neuropathy, diabetic
neuropathy, iatrogenic
neuropathy, immune
neuropathy, medication induced
neuropathy, motor
neuropathy, motor, multifocal
neuropathy, multifocal
neuropathy, painful
neuropathy, peripheral
neuropathy, peripheral, treatment
neuropathy, sensory
neuropathy, toxic
neuropathy, vasculitic, systemic
neuroradiology, interventional
neurotoxic
nevus
new onset refractory status epilepticus
night sweats
nivolumab
NMDA antagonists
nocardiosis
nonsteroidal anti-inflammatory drug
nortriptyline
numbness, extremity
ocrelizumab
ocular motility, disorders of
oculovestibular reflex
ofatumumab
old age, neurology of
ophelia syndrome
ophthalmoplegia
ophthalmoplegia, painful
ophthalmoplegia, total
opisthotonus
opportunistic infection
opportunistic infection, CNS
optic chiasm
optic chiasm, lesion of
optic disc edema
optic nerve, enhancement
optic nerve, lesion of
optic neuritis
optic neuropathy
optic neuropathy, toxic
oral contraceptives
oral contraceptives, cerbrovascular disease and
orbit, biopsy
orbit, inflammation in
orbit, lesions of
orbit, pseudotumor of
orbital apex
organ transplantation
organomegaly
orthostatic hypotension
osteolytic lesion, causes of
overlap syndrome
pachymeningitis, cranial
pain
pain, abdominal
pain, arm
pain, back
pain, leg
pancreatitis
pancytopenia
papilledema
paralysis, acute
paralysis, asymmetric
paraneoplastic cerebellar degeneration
paraparesis
paraproteinemia
parasitic infection
parasitic infection, CNS
paraspinal muscle
paraspinal muscle weakness
paresthesias
paresthesias, feet
paresthesias, hands
parotid gland swelling
paroxysmal nocturnal hemoglobinuria
pathology
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
pembrolizumab
pentoxifylline
pericarditis
peripheral blood stem cell transplantation
personality change
pituitary stalk
pituitary stalk, enlarged
placebo
plasma cell dyscrasia
plasma cell myeloma, CNS involvement associated with
plasmacytoma
plasmapheresis
plasmapheresis, complications of
platelet inhibiting drugs
pleocytosis of cerebrospinal fluid
pleocytosis of cerebrospinal fluid, neutrophilic
pleural effusion
pneumonia
POEMS syndrome
polyclonal gammopathy
polycythemia, secondary
polymerase chain reaction
polymerase chain reaction, false negative
polymyalgia rheumatica
polymyositis
polyneuropathy
polyneuropathy, chronic idiopathic
polyneuropathy, chronic idiopathic, ataxic
polyneuropathy, chronic inflammatory demyelinating
polyneuropathy, chronic inflammatory demyelinating, variant form
polyneuropathy, chronic inflammatory demyelinating-pure motor syn
polyneuropathy, chronic inflammatory demyelinating-sens atax var
polyneuropathy, chronic inflammatory demyelinating-variant forms
polyneuropathy, chronic relapsing
polyneuropathy, subacute idiopathic demyelinating
polyneuropathy, uremic
polyradiculoneuropathy
pons, lesion of
pontine hemorrhage
positive sharp waves
post herpetic neuralgia
post transplant lymphoproliferative disease
posterior circulation stroke
posterior leukoencephalopathy syndrome
postoperative neurologic complications
postpartum
postural abnormality
potassium channel antibodies
practice guidelines
precipitating factors
preclinical
pregnancy, neurologic complications in
premarin
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
progressive neurologic disorder
progressive spinal muscular atrophy
proprioception, abnormal
proptosis
proptosis, unilateral
protozoan infection
pseudohypertrophy
psoriasis
psoriatic arthritis
psychiatric problems in neurologic disorders
psychosis
psychosis, childhood
psychotropic drugs
ptosis
ptosis, bilateral
pulmonary infiltrates
pulmonary nodules
purpura
quadriceps atrophy
quadriparesis
quadriplegia
quality of life
race
radiation therapy, CNS treatment and complications with
radiation therapy, total body
rapidly fatal neurologic illness
rapidly progressing neurologic illness
rash
ravulizumab
recanalization, arterial
recurrent
recurrent laryngeal nerve paralysis
regional enteritis
remote effect of cancer on the nervous system
remternetug
remyelination
renal failure
renal transplantation
reocclusion, cerebral artery
respiratory failure
retroperitoneal fibrosis
retrovirus
review article
rhabdomyolysis
rheumatoid arthritis
rheumatoid arthritis, neurologic complications of
rimegepant
risk factors
risk stratification
risk-benefit assessment
rituximab
Romberg's sign
rouleaux
rozanolixizumab
safety
salivary gland enlargement
sarcoidosis
sarcoidosis, CNS
sarilumab
schwannoma
sclerodactyly
scleromyxedema
sclerosis, bone
scotoma
screening
sedimentation rate
sedimentation rate, elevated
seizure
seizure, focal
seizure, intractable
seizure, psychomotor-temporal lobe
seizure, treatment of
sensory loss
sensory polyneuropathy
serologic testing
serologic testing, false negative
seronegative
seropositive
serotonin agonist
shared decision making
shoulder, pain in
sialadenitis
skin, biopsy
skin, lesions in neurologic disorders
skin, thickened
sleep pathology and physiology
small vessel vasculitis
soluble interlukin 2 receptor
somnolence
speech disorder
speech disorder, childhood
spinal cord
spinal cord, lesion of
splenic-vein thrombosis
splenomegaly
standing difficulty
status epilepticus
status epilepticus, intractable
stem cell transplantation
stent, basilar artery
stent, basilar artery, efficacy
stent, carotid artery, complications
steppage gait
steroid
steroid sparing therapy
steroid therapy, CNS treatment and complications with
stiff joints
stooped posture
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
strokelike episodes
subarachnoid hemorrhage
sumatriptan
systemic illness
T cell lymphocytes
tacrolimus
tamoxifen
temozolomide
temporal artery, biopsy
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
teriflunomide
thalamus, lesion of
thalamus, lesion of-bilateral
thrombocytopenia
thrombocytosis
thrombotic thrombocytopenia purpura
thymectomy
thymic hyperplasia
thymoma
thyroiditis
tissue plasminogen activator, intravenous
tocilizumab
tongue, atrophy
tongue, fasciculations of
toxoplasmosis, acquired
toxoplasmosis, CNS
TRAILBLAZER-ALZ trial
transcutaneous electrical nerve stimulation
transient ischemic attack
transluminal angioplasty, carotid artery
transluminal angioplasty, coronary artery
transluminal angioplasty, intracranial
treatment of neurologic disorder
treatment resistant
tremor
tricyclic antidepressant
trigeminovascular system
triptans
troponin T
tuberculosis
tumor necrosis factor
tumor necrosis factor inhibitor
ultrasonography
ultrasonography, carotid artery
upadacitinib
urinary tract infection
urticaria
uveitis
vaccination, neurologic complications with
vaccine
vagus nerve stimulation
varicella zoster virus
varicella zoster virus, encephalitis
varicella zoster virus, vasculopathy
vascular endothelial growth factor
vasculitides
vasculopathy
ventricular assist device
verapamil
vertebral artery
vertebral artery disease
vertebral artery occlusion
vertebral-basilar artery, intraluminal clot
vertebral-basilar insufficiency
vertebrobasilar artery thickening
vertebrobasilar, artery stenosis
vibratory sensation, abnormal
viral infection
viral infection, CNS
viral infection, reactivation
viral load
viremia
viruria
vision, blurred
visual acuity
visual acuity, decreased
visual acuity, decreased, monocular
visual field defect
visual impairment
visual loss
visual loss, slow-unilateral
vitamin deficiency
vocal cord paralysis
vomiting, intractable
Waldenstrom's macroglobulinemia
walking, difficulty with
water channel antibodies
weakness
weakness, acute
weakness, fatiguable
weakness, generalized
weakness, progressive
weakness, proximal
weight loss
wheelchair
white matter disease
white matter disease, subcortical
whites
wide based gait
workup
zilucoplan
Showing articles 0 to 50 of 331 Next >>

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025

Adverse Events Associated with Disease-Modifying Drugs for Multiple Sclerosis
Neurol 102:e208006, Ng, HS.,et al, 2024

Inhibition of CD40L with Frexalimab in Multiple Sclerosis
NEJM 390:589-600, 662, Vermersch,P.,et al, 2024

Diagnosis and Management of ANCA-Associated Vasculitis
Lancet 403:683-698, Kronbichler, A., et al, 2024

Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024

Clinical Presentation, Management, and Outcome in Neurolymphomatosis, A Systematic Review
Neurol 103:e209698, Kaulen.L.D.,et al, 2024

Chronic Immunotherapy for Myasthenia Gravis
www.UptoDate.Com, Bird,S.J., 2024

Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine, A Phase 4, Randomized, Placebo-Controlled Trial
JAMA Neurol 81:1140-1149, Tepper,S.J.,et al, 2024

Amyloid-Related Imaging Abnormalities:An Update
AJR 220:562-575, Roytman,M.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

A 67-Year-Old Woman with Progressive Tingling Sensations and Imlalance
Neurol 100:151-157, Horta,L.F.B.,et al, 2023

Progressive Camptocormia with Head Drop and Dysphagia
JAMA Neurol 80:209-210, El-Wahsh,S., et al, 2023

A 60-Year Old Man with Asymmetric Weakness and Persistent Fever
Neurol 100:530-536, Zheng,Y.,et al, 2023

Progressive Hemiparesis and White Matter Abnormalities in an HIV-Negative Patient
Neurol 100:1156-1163, Jabbari,E.,et al, 2023

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Lecanemab, Looking Before We Leap
Neurol 101:661-665, Burke,J.F.,et al, 2023

Polymyalgia Rheumatica
Lancet 402:1459-1472, Espigol-Frigole,G.,et al, 2023

Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023

Atypical Presentation of Primary Angiitis of Central Nervous System Responsive to Rituximab
Stroke 53:e490-e494, Kesav, P.,et al, 2022

Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients with Early Alzheimer Disease
Neurol 98:e968-e977, Whittington, M.D.,et al, 2022

Recent Advances in the Diagnosis and Management of Cluster Headache
BMJ 376:e059577, Schindler, E. & Burish, M.J., 2022

Rituximab Therapy in the Treatment of Juvenile Myasthenia Gravis
Neurol 98:e2368-e2376, Molimard, A.,et al, 2022

A New Option is Approved for Patients with Myasthenia Gravis
JAMA 327:417, Voelker, R., 2022

Clinicopathologic Conference, Plasm-Cell Myeloma Post-Transplant Lymphoproliferative Disorder
NEJM 386:2508-2516, Case 20-2022, 2022

A 48-Year-Old Woman with 6 Months of Vivid Visual Hallucinations
Neurol 99:166-171, Kizza, J.,et al, 2022

Neuromyelitis Optica Spectrum Disorder
NEJM 387:631-639, Wingerchuk, D.M. & Lucchinetti, C.F., 2022

Progressive Vertebrobasilar Vasculopathy and Stroke Secondary to Giant Cell Arteritis
Stroke 53:e435-e438, Mahjoub, Y.,et al, 2022

Clinicopathologic Conference, Encephalitis due to Behcets Disease
NEJM 387:925-933, Case 27-2022, 2022

Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021

Autoimmune Encephalitis Related to Cancer Treatment with Immune Checkpoint Inhibitors
Neurol 97:e191-e202, Nersesjan, V.,et al, 2021

Pembrolizumab-Induced Migrating Cortico-Subcortical Brain Lesions
Ann Neurol 89:1255-1256, Lambert, N.,et al, 2021

Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021

A Brewing Back Pain
NEJM 385:66-72, Pischel, L.,et al, 2021

Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021

Aducanumab: What About the Patient?
Ann Neurol 90:334-335, Petersen, R.C., 2021

Drugs Associated with Ischemic Stroke
Stroke 52:e646-e659, Marto, J.P.,et al, 2021

Progressive Multifocal Leukoencephalopathy in a Patient with Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy
JAMA Neurol 78:736-740, Patel,A.,et al, 2021

Two Cases of Meningitis Associated with Ocrelizumab Therapy
Mult Scler Rel Dis 38:101866, Theriault, M. & Solomon, A.J., 2020

Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020

Management and Outcome of Primary CNS Lymphoma in the Modern Era
Neurol 94:e1027-e1039, Houillier, C., et al, 2020

A 59-year-old Woman with Multiple Myeloma and Lower Extremity Weakness and Numbness
Neurol 94:794-800, Gadot, R.,et al, 2020

Relapse of Severe Neurosarcoidosis with Switch from Originator Infliximab to Biosimilar
Neurol 94:991-993, Kidd, D.P.,et al, 2020

Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020

Second Drug Okayed for Rare Central Nervous System Disease
JAMA 324:224, Jaklevic, M.C., 2020

Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020

One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020



Showing articles 0 to 50 of 331 Next >>